[Cardiovascular disorders in patients infected with 2019 novel coronavirus].

Atteintes du système cardiovasculaire chez les patients atteints de maladie à coronavirus 19.
COVD-19 COVID-19 Coronavirus Cœur Heart ICU Mortality Mortalité Prognosis Pronostic Soins intensifs

Journal

Annales de cardiologie et d'angeiologie
ISSN: 1768-3181
Titre abrégé: Ann Cardiol Angeiol (Paris)
Pays: France
ID NLM: 0142167

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 21 09 2020
accepted: 04 11 2020
pubmed: 2 3 2021
medline: 21 4 2021
entrez: 1 3 2021
Statut: ppublish

Résumé

The coronavirus disease 2019 (COVID-19) outbreak has become a worldwide public health concern. Cardiovascular complications are relatively frequent, reaching 20% of COVID-19 patients and 43% of COVID-19 patients admitted in Intensive Care Unit. Cardiac injury mechanisms are multiple, including hyperinflammation, pro-coagulant and pro-thrombotic states, sepsis related cardiomyopathy, hypoxia in relation with lung severity, hemodynamic instability, cytokine storm, critically illness, direct myocardial insult by acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and stress cardiomyopathy. The authors report a narrative review about cardio-vascular complications and predictive factors of mortality in patients infected with COVID-19.

Identifiants

pubmed: 33642045
pii: S0003-3928(20)30192-X
doi: 10.1016/j.ancard.2020.11.004
pmc: PMC7682417
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

106-115

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

V Aidan (V)

Département de cardiologie, centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, hôpital Ambroise-Paré, université de Versailles-Saint Quentin (UVSQ), AP-HP, Boulogne-Billancourt, France.

B Davido (B)

Service de maladies infectieuses, CHU de Raymond-Poincaré, AP-HP, Garches, France.

H Mustafic (H)

Département de cardiologie, centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, hôpital Ambroise-Paré, université de Versailles-Saint Quentin (UVSQ), AP-HP, Boulogne-Billancourt, France; Inserm U-1018, CESP, UVSQ, Villejuif, France.

A Dinh (A)

Service de maladies infectieuses, CHU de Raymond-Poincaré, AP-HP, Garches, France.

N Mansencal (N)

Département de cardiologie, centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, hôpital Ambroise-Paré, université de Versailles-Saint Quentin (UVSQ), AP-HP, Boulogne-Billancourt, France; Inserm U-1018, CESP, UVSQ, Villejuif, France.

A Fayssoil (A)

Département de cardiologie, centre de référence des cardiomyopathies et des troubles du rythme cardiaque héréditaires ou rares, hôpital Ambroise-Paré, université de Versailles-Saint Quentin (UVSQ), AP-HP, Boulogne-Billancourt, France; Unité de cardiologie, CHU de Raymond-Poincaré, AP-HP, Garches, France. Electronic address: abdallah.fayssoil@aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH